Analysis Report
In-depth Analysis of Representative Director Kim Jin-kook
Started as Kim Jin-kook Eye Clinic in 1994, it is one of the largest ophthalmology clinics in Korea with over 30 years of history and over 500,000 eyes operated on.
The self-developed AI vision correction prediction system was published in *Nature Digital Medicine*, securing academic reliability.
Focuses on SMILE LASIK and next-generation SMILE Pro (introducing VisuMax 800), emphasizing high astigmatism correction and rapid recovery.
While systematic system and data-based diagnosis are well-received, mixed feelings exist regarding waiting times and mechanical treatment processes.
Representative Director
Director Kim Jin-kook is a 'Digital Healthcare' leader who believes "objective data is more important than a doctor's subjective judgment." He digitized over 20 years of surgery data and established Visuworks, a medical AI solution startup, leading the development of the AI vision correction prediction system with a goal to expand into a global medical platform.
B&VIIT Eye Center combines the external perception of being 'factory-style' with an internal goal of 'systematized precision treatment'.
Technical Principles and Data: Utilizes over 500,000 accumulated surgery data points since 1994, trained on Machine Learning algorithms. The AI analyzes past surgery results of similar eye conditions to present suitable surgical methods and expected corrected vision.
Academic Achievements (Nature Digital Medicine): This system was published in 'Nature Digital Medicine' in 2019, proving its ability to diagnose surgery feasibility with 98% accuracy. This highlights the hospital's academic research capabilities.
Major directors, including Representative Director Kim Jin-kook, Ryu Ik-hee, and Lee In-sik, are trusted for their extensive experience and academic achievements. However, patients should consider that receiving surgery directly from the representative director may incur additional costs or longer waiting times, and employed doctors (pay doctors) may change frequently.
B&VIIT Eye Center is evolving beyond a simple hospital into a "Data-based Vision Correction Platform." The AI system under Director Kim Jin-kook's leadership and the introduction of VisuMax 800 provide a significant technological edge.
30 years and over 500,000 eye cases form the foundation for AI prediction accuracy.
Highly active in adopting new technologies from LASEK to SMILE Pro and AI diagnosis.
Provides efficient, standardized medical services, but can be a weakness in personalized emotional care.
B&VIIT Eye Center is a suitable option for patients seeking "safe and verified standardized surgery." Especially for those with high astigmatism or complex eye conditions, the technological benefits of AI analysis and SMILE Pro are significant. However, if a patient prioritizes 'close communication with the doctor and detailed 1:1 care,' they should fully understand the treatment system's characteristics and actively request designated director treatment.
Ultimately, B&VIIT Eye Center represents a successful model combining 'scaling up' and 'high-tech' in the Korean medical market, with Representative Director Kim Jin-kook solidifying his position as an innovator fusing clinical practice and technology.